Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

Go back to Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
(NASDAQ: COCH) Delayed: 0.65 -0.01 (1.52%)
Previous Close $0.66    52 Week High
Open $0.66    52 Week Low
Day High $0.67    P/E N/A 
Day Low $0.65    EPS
Volume 7,483